Sabinsa, the multi-national health science company, will showcase its portfolio of innovative ingredients at Vitafoods Europe 2024 from 16—18 May, at the Palexpo SA International Exhibition Centre in Geneva, Switzerland.
As the official curcumin sponsor of the event, Sabinsa will highlight its product, C3 Reduct - the only EFSA-approved curcuminoid product in the European market.
Among the portfolio of science-backed in ingredients Sabinsa will showcase at Vitafoods Europe are:
- C3 Reduct: A pioneering formulation offering optimised Curcuminoids with enhanced bioavailability and efficacy
- Cirpusins: Derived from Cyperus rotundus, the product is clinically shown to aid in weight management, including in obese patients
- Saberry: Extracted from Amla and standardised to 10% beta-glucogallin, Saberry is clinically studied for its effectiveness in supporting healthy lipid and glucose levels
- Nigellin: (general health & wellness), extract from the seeds of Nigella sativa (Black Cumin Seed) standardised for 5% and 20% Thymoquinone
- Shagandha: Featuring correctly standardised Ashwagandha using USP methodology; recent studies show its potential in reducing stress and anxiety
“I am looking forward to meeting with our European customers at Vitafoods to discuss how our ingredients and expertise can support their brand success,” said Shaheen Majeed, Global CEO and Managing Director of Sabinsa.
Sabinsa invites attendees to visit Stand A90, where the European team, led by Dr Umar Jan, President of European Operations, will be present to discuss and demonstrate how Sabinsa’s market-oriented approach in Europe continues to provide high-quality products, exceptional service and technical sales support to nurture and grow their European client base.
